Judicial Panel Consolidates Fosamax Femur Fracture Suits

Law360, New York (May 23, 2011, 8:51 PM EDT) -- The U.S. Judicial Panel on Multidistrict Litigation centralized 36 lawsuits in New Jersey federal court on Monday that accuse Merck & Co. Inc. of negligence and other claims over femur fractures and similar injuries allegedly caused by its osteoporosis drug Fosamax.

Acting on Merck's request, the JPML found the actions spread out across eight federal court districts all involve common questions of fact and allegations over the drug and its generic equivalent. According to the panel, the District of New Jersey is the appropriate forum because...
To view the full article, register now.